Skip to main content

and
  1. No Access

    Article

    Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer

    Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective against non-small cell lung cancer (NSCLC) with EGFR-activating mutations. The mechanisms underlying EGFR-TKI resistance are n...

    Shiqi Ma, Lu Zhang, Yuan Ren, Wei Dai, Tingqing Chen, Li** Luo, Juan Zeng in Oncogene (2021)

  2. Article

    Open Access

    Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis

    After esophagectomy, adjuvant chemotherapy (S + CT) and adjuvant chemoradiotherapy (S + CRT) can improve survival in patients with node-positive resectable esophageal cancer. However, we are not aware of any s...

    Qifeng Wang, **yi Lang, Tao Li, Lin Peng, Wei Dai, Yinchun Jiang in Radiation Oncology (2020)

  3. No Access

    Article

    Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes

    γδ T cells are a unique lymphocyte population that have been reported to have either anti- or pro-tumoral functions in several cancer types, but the mechanisms are underinvestigated. Exosomes, initially consid...

    Ling Li, Bangrong Cao, **nhua Liang, Shun Lu, Huaichao Luo, Zhaohui Wang in Oncogene (2019)

  4. Article

    Open Access

    A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer

    The clinical benefit of adjuvant chemotherapy for stage II colorectal cancer (CRC) is controversial. This study aimed to explore novel gene signature to predict outcome benefit of postoperative 5-Fu-based ther...

    Bangrong Cao, Li** Luo, Lin Feng, Shiqi Ma, Tingqing Chen, Yuan Ren in BMC Cancer (2017)